Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

19992,184 citationsJournal Article

Authors

Laura F. Hutchins · University of Arkansas for Medical Sciences

Joseph M. Unger · SWOG Cancer Research Network

John J. Crowley · SWOG Cancer Research Network

Abstract

There is substantial underrepresentation of patients 65 years of age or older in studies of treatment for cancer. The reasons should be clarified, and policies adopted to correct this underrepresentation.

Topics & Keywords

Ethics in Clinical Research Health Systems, Economic Evaluations, Quality of Life Biomedical Ethics and Regulation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 341, Issue 27, pp. 2061-2067

DOI: 10.1056/nejm199912303412706

Field-Weighted Citation Impact: 42.75